quote.fool.comToday's FeaturesQuotes, News, Charts, Data

 

 

 

 

 

 

   
Free Home Delivery!

Cash-King Port

The Cash King Portfolio has been renamed the Rule Maker Portfolio.

Report
Archives
Information
Messages
Companies Messages

11 Steps:
 1: Philosophy
 2: Mastering Finances
 3: Allocating Savings
 4: Finding Ideas
 5: Getting Information
 6: Cash-King Criteria
 7: QuaVa & Flow
 8: Ownership
 9: Putting It Together
10: Retirement
11: Getting Answers

What's our next portfolio pick? Our trade alerts let you know when the Fool makes a move. Read about our Fool PortTracker too.

Related Items

• Hall of Portfolios
• Rule Breaker Port
• Rule Maker Port
• Boring Port
• Drip Port
• Foolish Four Port
• Harry Jones


C-K Thumping Market

by Rob Landley
(landley@flash.net)

Austin, TX (Aug. 17, 1998) -- In the past few weeks, we've had a lot of days like Friday where our portfolio beat the market by falling more slowly than the indices did. While that might not sound comforting, we believe that it counts just as much to beat the indices on down days as it does to finish ahead of the market on up days.

The final aim is outperformance of the market's average return, as measured by the S&P 500. Given that nine out of ten mutual funds have lost to that average in the 1990s -- while charging considerably more than a simple index fund -- and given that the Cash-King Portfolio is free for anyone on the planet to read (with trading commissions down to $5 through online brokers), you can understand why we expect this column to be one of the most popular financial features online over the next decade. It's simple, convenient, logical, and aren't we a bunch of fun to hang out with each afternoon?!

Ok, strike the last one.

Now, why did we beat the market again this past week? Stock market gurus like to call it a "flight to quality," but then they rely heavily on the latest news without much concern for financial education. If they'd flip flop those, we'd have less drivel about why the market did what it did on any given day, in any given hour, and we'd have much more focus on how to find that quality that people are ever flying to.

But, that's just me being a curmudgeon again.

Let's take a look at the numbers for the week:

 
 Cash-King    Last    This Change 
 Gap Inc.   $62.56  $62.94  +0.6% 
 Cisco      $96.88  $96.44  -0.5% 
 Intel      $86.69  $86.19  -0.6% 
 T Rowe     $35.13  $34.63  -1.4% 
 Microsoft $105.88 $104.25  -1.5% 
 Pfizer    $103.63 $101.19  -2.4% 
 Coca-Cola $80.44   $76.81  -4.5% 
 AmEx      $101.13  $93.69  -7.4% 
  
  
 Fool Four    Last    This Change 
 Chevron    $77.38  $80.13  +3.6% 
 Exxon      $66.94  $68.38  +2.2% 
 Kodak      $83.56  $82.50  -1.3% 
 GM         $71.06  $67.81  -4.6% 
  
 S&P 500      1089    1063  -2.4% 
 Total C-K $22,703 $22,337  -1.6% 
 

All told, since our inception the Cash-King portfolio is up 11.69% versus gains by the S&P 500 of 6.14% (as of Monday market open). Imagine for a second that those were annual gains, and play along as we compound the differences between the two rates over the next 40 years. If the S&P 500 were to grow 6.14% per year over the next four decades, then our $22,337 would grow to over $242,000. If, instead, our portfolio grew at that 11.69% per year over four decades, the account would grow to $1.86 million.

Seemingly small differences today can prove enormous tomorrow.

Ok, let's take a look at the news from our companies last week:

Pfizer

Possibly the best news of the week was that Pfizer (NYSE: PFE) sold the last of its Medical Technologies group, the Howmedica orthopedic products unit, to surgical products make Stryker Corp. for $1.9 billion. Pfizer has decided it needn't try to be Johnson & Johnson, instead choosing to focus tightly on its high-margin drug business. (Isn't it nice to own a company that sells off a subsidiary for nearly 2.5x sales because it wasn't valuable enough for Pfizer shareholders?)

That's a big part of the reason we picked Pfizer over J&J. Since we can diversify our portfolio into as many different stocks as we want, why would we want the individual companies we invest in to diversify away from whatever makes them the most money? The sale of Howmedica gets Pfizer out of the orthopedic products business and leaves it with another $2 billion to invest in its higher-margin pharmaceuticals business. Way to go Pfizer!

Gap

There is no force on earth that can stop Tom Gardner from talking at length next week about Gap's (NYSE: GPS) recent conference call (click that to read it), but I would recommend dropping by the Cash-King companies folder to run the numbers on this most recent quarter. In terms of our C-K criteria, they look pretty darn nice! This made for the second-best news of the week for our portfolio.

Coke

I didn't see a whole lot of news from Coke (NYSE: KO) this week. Here are a couple of articles. On the fifth of the month, TMF compared the current market to the Nifty Fifty in the Evening News, using Coke as the first example. And Reuters released an article a few days later comparing the current market to the Nifty Fifty, using Coke as its first example (High Nifty Fifty valuations). Let's just hope folks recognize that the investor who bought Coke stock at its high in the winter of 1972, right before the bear market, and then held it through to today would have earned pronounced market OUTperformance. Pretty nifty.

T. Rowe Price

As always, there was little news on T. Rowe Price (Nasdaq: TROW), but the company was footnoted in an interesting AP article on how individual investors ignored the recent market turbulence: Slide Doesn't Panic Small Investors.

American Express

Our dog of the month of August, American Express (NYSE: AXP) continued lower on concerns about its exposure to the Asian markets.

Cisco

Cisco (Nasdaq: CSCO) sold more stuff, got some big contracts, and was challenged by new start-ups, none of which I'd actually call news...

Microsoft

Microsoft (Nasdaq: MSFT) spent the week in court again. (Did I really NEED to say that?) It hasn't had much luck lately, having been forced to turn over the Windows 95 source code. (It turns out it can't force the Department of Justice to sign a non-disclosure agreement -- no surprise there.) It also can't limit the amount of testimony Bill Gates and other Microsoft executives will give to the court. And it can't even keep reporters out of the courtroom while he's testifying. Naturally, Mr. Softy has filed a motion to dismiss the entire case.

But, the boxers aren't even in the ring; the real action hasn't yet started. And I expect cases like this to play a very large role in Microsoft's business over the next fifteen years. Here are some interesting recent articles about Microsoft:

1. Judge Says Gates Must Face Prosecutors
2. Web Developers Criticize Microsoft and Netscape
3. Computer Users Fight 'Bloatware'
4. Microsoft Countersues Justice Department
5. States Still Probing Microsoft Office
6. Microsoft Office 2000 to Open on the Web
7. Microsoft Wants Dismissal of Antitrust Suit
That's enough reading for the week. I'll postpone discussion of Intel for now, but wow, how about that rebound?! Go Intel.

I hope everybody survived last Monday intact. I'm told there was another one scheduled for today, and that Mondays are slated for every week over the next fifty years at least. Even when the markets are down, I think we can get through them, Foolishly.

- Rob Landley (Oak)


08/17/98 Close
Stock  Change    Bid 
 AXP   +2 7/16  96.13 
 CHV   +  13/16 80.94 
 CSCO  +1 11/16 98.13 
 KO    +2 1/4   79.06 
 GPS   +1 5/8   64.56 
 EK    +3 1/16  85.56 
 XON   +1 3/16  69.56 
 GM      ---    67.81 
 INTC  +3 3/8   89.56 
 MSFT  +3 1/16  107.31 
 PFE   +3 7/16  104.63 
 TROW  +  3/8   35.00 
 

                  Day   Month    Year  History 
         C-K      +2.44%  -1.00%  14.41%  14.41% 
         S&P:     +1.97%  -3.30%   8.23%   8.23% 
         NASDAQ:  +1.56%  -2.90%   9.99%   9.99% 
  
 Cash-King Stocks 
  
     Rec'd    #  Security     In At       Now    Change 
     2/3/98   24 Microsoft     78.27    107.31    37.11% 
     2/3/98   22 Pfizer        82.30    104.63    27.13% 
     5/1/98   37 Gap Inc.      51.09     64.56    26.37% 
    2/27/98   27 Coca-Cola     69.11     79.06    14.41% 
    6/23/98   23 Cisco Syst    86.35     98.13    13.64% 
    2/13/98   22 Intel         84.67     89.56     5.77% 
     2/6/98   56 T. Rowe Pr    33.67     35.00     3.94% 
    5/26/98   18 American E   104.07     96.13    -7.63% 
  
 Foolish Four Stocks 
  
     Rec'd    #  Security     In At     Value    Change 
    3/12/98   20 Eastman Ko    63.15     85.56    35.50% 
    3/12/98   20 Exxon         64.34     69.56     8.13% 
    3/12/98   15 Chevron       83.34     80.94    -2.89% 
    3/12/98   17 General Mo    72.41     67.81    -6.34% 
  
 Cash-King Stocks 
  
     Rec'd    #  Security     In At     Value    Change 
     2/3/98   24 Microsoft   1878.45   2575.50   $697.05 
     5/1/98   37 Gap Inc.    1890.33   2388.81   $498.48 
     2/3/98   22 Pfizer      1810.58   2301.75   $491.17 
    6/23/98   23 Cisco Syst  1985.95   2256.88   $270.93 
    2/27/98   27 Coca-Cola   1865.89   2134.69   $268.80 
    2/13/98   22 Intel       1862.83   1970.38   $107.55 
     2/6/98   56 T. Rowe Pr  1885.70   1960.00    $74.30 
    5/26/98   18 American E  1873.20   1730.25  -$142.95 
  
 Foolish Four Stocks 
  
     Rec'd    #  Security     In At     Value    Change 
    3/12/98   20 Eastman Ko  1262.95   1711.25   $448.30 
    3/12/98   20 Exxon       1286.70   1391.25   $104.55 
    3/12/98   15 Chevron     1250.14   1214.06   -$36.08 
    3/12/98   17 General Mo  1230.89   1152.81   -$78.08 
  
                               CASH     $94.76 
                              TOTAL  $22882.39 
   
 *Please note: On 8/4/98 $2,000 cash was added to the
portfolio for future investment. This will be reflected
in the numbers as soon as possible.

*The year for the S&P and Nasdaq will be as of 02/03/98

</THE CASH-KING PORTFOLIO>

Are you a Foolish investor?
The Motley Fool Recommends...
Industry Snapshot
New format! A stock idea, industry overview, top players, and financials -- every two weeks! Get more info or order.

ValuTool 2.0
You give it the data, and it does the rest: PEG & Foolish 8 valuations, ratio valuations, and lots more. Get more info or order.

Foolish Eight Stock Screen
Here at Last! Foolish Eight Stock Screen. Get more info or order.
Other Fool Products...
Subscriptions
Primers
Reports
Investing Tools
Books
Fool Gear

Shop FoolMart!

 

  home  | news  | specials  | strategies  | personal finance  | school  | help  

© Copyright 1995-2000, The Motley Fool. All rights reserved. This material is for personal use only. Republication and redissemination, including posting to news groups, is expressly prohibited without the prior written consent of The Motley Fool. The Motley Fool is a registered trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us